Cargando…
What happened to microbiological diagnosis in 2020 beyond COVID-19?
The global pandemic of COVID-19 has had negative repercussions on the activities and research in clinical microbiology laboratories other than those related to SARS-CoV-2. Nonetheless, the research activity has also continued in other fields. In this brief review, some of the recent publications rel...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Quimioterapia
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683012/ https://www.ncbi.nlm.nih.gov/pubmed/34598413 http://dx.doi.org/10.37201/req/s01.01.2021 |
_version_ | 1784617326557003776 |
---|---|
author | Cercenado, Emilia |
author_facet | Cercenado, Emilia |
author_sort | Cercenado, Emilia |
collection | PubMed |
description | The global pandemic of COVID-19 has had negative repercussions on the activities and research in clinical microbiology laboratories other than those related to SARS-CoV-2. Nonetheless, the research activity has also continued in other fields. In this brief review, some of the recent publications related to new diagnostic tests, methods for rapid antimicrobial susceptibility testing and for the detection of resistance genes, new diagnostic technologies, and some aspects related to old and emergent pathogens (Candida auris, Elizabethkingia spp. Streptococcus pyogenes) are summarized. |
format | Online Article Text |
id | pubmed-8683012 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Sociedad Española de Quimioterapia |
record_format | MEDLINE/PubMed |
spelling | pubmed-86830122021-12-29 What happened to microbiological diagnosis in 2020 beyond COVID-19? Cercenado, Emilia Rev Esp Quimioter Update in Infection Diseases 2020 The global pandemic of COVID-19 has had negative repercussions on the activities and research in clinical microbiology laboratories other than those related to SARS-CoV-2. Nonetheless, the research activity has also continued in other fields. In this brief review, some of the recent publications related to new diagnostic tests, methods for rapid antimicrobial susceptibility testing and for the detection of resistance genes, new diagnostic technologies, and some aspects related to old and emergent pathogens (Candida auris, Elizabethkingia spp. Streptococcus pyogenes) are summarized. Sociedad Española de Quimioterapia 2021-09-30 2021 /pmc/articles/PMC8683012/ /pubmed/34598413 http://dx.doi.org/10.37201/req/s01.01.2021 Text en © The Author 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/). |
spellingShingle | Update in Infection Diseases 2020 Cercenado, Emilia What happened to microbiological diagnosis in 2020 beyond COVID-19? |
title | What happened to microbiological diagnosis in 2020 beyond COVID-19? |
title_full | What happened to microbiological diagnosis in 2020 beyond COVID-19? |
title_fullStr | What happened to microbiological diagnosis in 2020 beyond COVID-19? |
title_full_unstemmed | What happened to microbiological diagnosis in 2020 beyond COVID-19? |
title_short | What happened to microbiological diagnosis in 2020 beyond COVID-19? |
title_sort | what happened to microbiological diagnosis in 2020 beyond covid-19? |
topic | Update in Infection Diseases 2020 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683012/ https://www.ncbi.nlm.nih.gov/pubmed/34598413 http://dx.doi.org/10.37201/req/s01.01.2021 |
work_keys_str_mv | AT cercenadoemilia whathappenedtomicrobiologicaldiagnosisin2020beyondcovid19 |